2019 annual financial data

China SXT Pharmaceuticals 2019 Financial results

Direct answer

Revenue was 7,012,026 USD.

Operating income was 1,769,492 USD and net income was 1,539,227 USD.
Operating cash flow was 239,192 USD.

Get free China SXT Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
7,012,026 USD
Operating income
1,769,492 USD
Net income
1,539,227 USD
Operating cash flow
239,192 USD